14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
LITE vs NVT: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
LITE Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 4–6 Matrix Metrics)
LITE Overall Winner
6-Pillar Tally: LITE 4 – 2 NVT
Matrix Metrics: LITE 4 – 6 NVT
As of Nov 16, 2026, Lumentum Holdings Inc. (LITE) is the stronger overall head-to-head candidate over nVent Electric plc (NVT) in the Tradestie Institutional Equity Comparison Engine, winning 4–6 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Options & Positioning). LITE carries a Unified Composite Score of 58.0/100 (HOLD) at $546.65 (17.9x Forward P/E, 23.4% operating margin), whereas NVT carries 59.3/100 (HOLD) at $108.51 (16.4x Forward P/E, 17.7% operating margin).
Composite vs. Pillar Nuance: While NVT currently prints a higher short-term Unified Composite Score (59.3/100 HOLD vs. LITE 58.0/100 HOLD), LITE captures the overall institutional head-to-head verdict (4–6 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (23.4% vs. 17.7% operating margin) and revenue trajectory (+136.5% vs. +43.7% YoY).
Technical & Structure Timing Caution: LITE is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.9); meanwhile NVT is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 36.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Competes within the Communication Equipment value chain with $53.6B market capitalization and 23.4% operating margin.
OpEx & R&D Reinvestment24.6% of Rev ($921M)
90D Engineering Disclosures0 Published · Silicon Photonics
Mapped Supply-Chain Ecosystem (18 partners):
CorningCoherentSumitomo Electric IndustriesFurukawa Electric
NVT Moat ProfileScale & Operating Efficiency Moat
Electrical Equipment & Parts Operator
Competes within the Electrical Equipment & Parts value chain with $18.7B market capitalization and 17.7% operating margin.
OpEx & R&D Reinvestment18.5% of Rev ($980M)
90D Engineering Disclosures0 Published
Investor FAQ LITE vs NVT Key Questions & Quantitative Answers
As of Nov 16, 2026, Lumentum Holdings Inc. (LITE) is the stronger overall head-to-head candidate over nVent Electric plc (NVT) in the Tradestie Institutional Equity Comparison Engine, winning 4–6 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Options & Positioning). LITE carries a Unified Composite Score of 58.0/100 (HOLD) at $546.65 (17.9x Forward P/E, 23.4% operating margin), whereas NVT carries 59.3/100 (HOLD) at $108.51 (16.4x Forward P/E, 17.7% operating margin). Composite vs. Pillar Nuance: While NVT currently prints a higher short-term Unified Composite Score (59.3/100 HOLD vs. LITE 58.0/100 HOLD), LITE captures the overall institutional head-to-head verdict (4–6 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (23.4% vs. 17.7% operating margin) and revenue trajectory (+136.5% vs. +43.7% YoY). Technical & Structure Timing Caution: LITE is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.9); meanwhile NVT is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 36.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
LITE leads the Growth & Scale pillar: LITE posts +136.5% YoY revenue growth and N/A YoY earnings growth on $3.74B TTM revenue (48.0% gross margin, 23.4% operating margin), compared with NVT at +43.7% YoY revenue growth and +65.4% YoY earnings growth on $5.29B TTM revenue (36.2% gross margin, 17.7% operating margin). Across the 8-period historical trajectory (FY2019 to FY2026), LITE cumulative revenue shifted +91.7% while NVT shifted +76.8%. In operating R&D and SG&A reinvestment, LITE deploys 24.6% of Rev ($921M) (0 90-day corporate R&D disclosures) versus 18.5% of Rev ($980M) (0 disclosures) for NVT.
NVT screens cheaper on headline valuation multiples. LITE trades at 17.9x Forward P/E, 29.3x Trailing P/E, 0.63x PEG, and 14.4x EV/Revenue (9.5% FCF margin), whereas NVT trades at 16.4x Forward P/E, 28.0x Trailing P/E, 0.61x PEG, and 3.8x EV/Revenue (12.1% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against LITE (-245.8% ROE) versus NVT (17.4% ROE) capital efficiency.
In options market volatility and institutional positioning, LITE carries 76.7% implied volatility (13th %ile, Compressed (<25th %ile)), a 1.23x (Put-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (3.16β · 133% Vol realized risk). By comparison, NVT carries 70.3% implied volatility (31st %ile, Balanced (25th–60th %ile)), a 0.02x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (2.33β · 100% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.